Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / VNRX - Volition launches Nu.Q Vet Cancer Test in Asia via distributor

VNRX - Volition launches Nu.Q Vet Cancer Test in Asia via distributor

VolitionRX Limited
VolitionRx (NYSE:VNRX) said it launched Nu.Q Vet Cancer Test for  companion animals in Asia through its distributor SAGE Healthcare. "Adding the Nu.Q® Vet Cancer Test to the routine wellness check-up for older dogs and at-risk breeds could help detect cancer early, when treatment is more effective and affordable," said Irene Kum, general manager for SAGE Healthcare. VolitionRx noted that SAGE was appointed in December 2021 to serve as a non-exclusive licensee and distributor of Nu.Q Vet Cancer Test in centralized labs in Singapore.

For further details see:

Volition launches Nu.Q Vet Cancer Test in Asia via distributor
Stock Information
Company Name: VolitionRX Limited
Stock Symbol: VNRX
Market: NYSE
Website: volition.com
Menu
VNRX VNRX Quote VNRX Short VNRX News VNRX Articles VNRX Message Board
Get VNRX Alerts

News, Short Squeeze, Breakout and More Instantly...